Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 413
5
Diseases
68
Unique genes
0.110
Avg. similarity score
Childhood-onset benign chorea with striatal involvement
Most-connected disease (3 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Childhood-onset benign chorea with striatal involvement
Conduct disorder
Dyskinesia, limb and orofacial, infantile-onset
Tooth disease
severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Childhood-onset benign chorea with striatal involvement | 3 | 3 | 1 |
| Conduct disorder | 3 | 3 | 52 |
| Dyskinesia, limb and orofacial, infantile-onset | 3 | 3 | 1 |
| Tooth disease | 2 | 2 | 18 |
| severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PDE10A | 4 / 5 | Childhood-onset benign chorea with striatal involvement, Conduct disorder, Dyskinesia, limb and orofacial, infantile-onset, Tooth disease |
| GATAD2B | 2 / 5 | Conduct disorder, severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| PPM1K | 2 / 5 | Conduct disorder, Tooth disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Tyrosine metabolism | KEGG | 3 / 36 | 14.7× | 1.08e-3 | 1.44e-2 ✓ sig. |
| Ethanol oxidation | Reactome | 2 / 12 | 29.4× | 2.01e-3 | 2.29e-2 ✓ sig. |
| RHO GTPases activate PKNs | Reactome | 2 / 20 | 17.7× | 5.62e-3 | 4.73e-2 ✓ sig. |
| Receptor-type tyrosine-protein phosphatases | Reactome | 2 / 20 | 17.7× | 5.62e-3 | 4.73e-2 ✓ sig. |
| Synaptic adhesion-like molecules | Reactome | 2 / 21 | 16.8× | 6.19e-3 | 5.04e-2 |
| PAOs oxidise polyamines to amines | Reactome | 1 / 2 | 88.3× | 1.13e-2 | 7.37e-2 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | Reactome | 1 / 2 | 88.3× | 1.13e-2 | 7.37e-2 |
| Adherens junction | KEGG | 3 / 93 | 5.7× | 1.57e-2 | 8.94e-2 |
| Interconversion of polyamines | Reactome | 1 / 3 | 58.9× | 1.69e-2 | 9.37e-2 |
| RUNX2 regulates osteoblast differentiation | Reactome | 1 / 3 | 58.9× | 1.69e-2 | 9.37e-2 |
| Axonal growth stimulation | Reactome | 1 / 4 | 44.2× | 2.25e-2 | 1.10e-1 |
| SLIT2:ROBO1 increases RHOA activity | Reactome | 1 / 4 | 44.2× | 2.25e-2 | 1.10e-1 |
| Reuptake of GABA | Reactome | 1 / 4 | 44.2× | 2.25e-2 | 1.10e-1 |
| Deactivation of the beta-catenin transactivating complex | Reactome | 2 / 42 | 8.4× | 2.35e-2 | 1.13e-1 |
| Fatty acid degradation | KEGG | 2 / 43 | 8.2× | 2.46e-2 | 1.15e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| chemical synaptic transmission | GO:0007268 | 6 / 236 | 7.0× | 2.17e-4 | 5.34e-3 ✓ sig. |
| cell surface receptor protein tyrosine phosphatase signaling pathway | GO:0007185 | 2 / 7 | 78.5× | 2.71e-4 | 6.25e-3 ✓ sig. |
| magnesium ion homeostasis | GO:0010960 | 2 / 8 | 68.7× | 3.60e-4 | 7.59e-3 ✓ sig. |
| single strand break repair | GO:0000012 | 2 / 12 | 45.8× | 8.41e-4 | 1.35e-2 ✓ sig. |
| ossification involved in bone maturation | GO:0043931 | 2 / 12 | 45.8× | 8.41e-4 | 1.35e-2 ✓ sig. |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | GO:0007187 | 3 / 54 | 15.3× | 1.00e-3 | 1.51e-2 ✓ sig. |
| detection of mechanical stimulus | GO:0050982 | 2 / 15 | 36.6× | 1.33e-3 | 1.79e-2 ✓ sig. |
| attachment of mitotic spindle microtubules to kinetochore | GO:0051315 | 2 / 19 | 28.9× | 2.14e-3 | 2.35e-2 ✓ sig. |
| epithelial cell morphogenesis | GO:0003382 | 2 / 19 | 28.9× | 2.14e-3 | 2.35e-2 ✓ sig. |
| positive regulation of cellular senescence | GO:2000774 | 2 / 20 | 27.5× | 2.38e-3 | 2.50e-2 ✓ sig. |
| central nervous system development | GO:0007417 | 4 / 158 | 7.0× | 2.63e-3 | 2.63e-2 ✓ sig. |
| negative regulation of protein secretion | GO:0050709 | 2 / 22 | 25.0× | 2.88e-3 | 2.76e-2 ✓ sig. |
| regulation of centrosome duplication | GO:0010824 | 2 / 22 | 25.0× | 2.88e-3 | 2.76e-2 ✓ sig. |
| Ras protein signal transduction | GO:0007265 | 3 / 79 | 10.4× | 2.99e-3 | 2.82e-2 ✓ sig. |
| androgen receptor signaling pathway | GO:0030521 | 2 / 23 | 23.9× | 3.14e-3 | 2.91e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Childhood-onset benign chorea with striatal involvement | Dyskinesia, limb and orofacial, infantile-onset | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Childhood-onset benign chorea with striatal involvement | Tooth disease | 0.053 | 1 | 1.17e-3 | 1.88e-3 ✓ sig. |
| Dyskinesia, limb and orofacial, infantile-onset | Tooth disease | 0.053 | 1 | 1.17e-3 | 1.88e-3 ✓ sig. |
| Childhood-onset benign chorea with striatal involvement | Conduct disorder | 0.019 | 1 | 3.38e-3 | 4.37e-3 ✓ sig. |
| Conduct disorder | Dyskinesia, limb and orofacial, infantile-onset | 0.019 | 1 | 3.38e-3 | 4.37e-3 ✓ sig. |
| Conduct disorder | severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | 0.019 | 1 | 3.38e-3 | 4.37e-3 ✓ sig. |